T Cell Responses to Tuberculin Purified Protein Derivative in Primary Biliary Cirrhosis: Evidence for Defective T Cell Function

Overview

Journal Gut

Specialty Gastroenterology

Date 1997 Feb 1

PMID 9071945

Citations 2

Authors

D E Jones

J M Palmer

M P Leon

S J Yeaman

M F Bassendine

A G Diamond

Affiliations

Soon will be listed here.

Abstract

Background: Primary biliary cirrhosis (PBC) has an autoimmune aetiology, although little is known regarding the mechanisms of breakdown of self tolerance. One postulated mechanism of control of self tolerance is through interacting T cell subsets, a phenomenon explored in this study.

Aims: To characterise and compare T cell subset responses to an antigen (tuberculin purified protein derivative derived from mycobacteria) in PBC patients and controls. Cross reactive responses to mycobacteria have recently been implicated in the aetiology of PBC.

Subjects: 58 PBC patients, 25 normal controls, and 34 chronic liver disease controls.

Methods: Responses to antigen were measured in terms of primary T cell proliferation and cytokine secretion (by ELISA). Responding cells were phenotyped by FACS analysis.

Results: Similar CD4+ T cell proliferative responses were seen in PBC patients (mean (SD) stimulation index (SI) 22.6 (27.2), 42 of 58 (72.4%) positive response), normal controls (46.5 (88.0), 17 of 25 (68%) positive), and chronic liver disease controls (24.8 (49.8), 27 of 34 (79.4%) positive)). Secretion of both interferon gamma and IL10 was significantly lower in PBC patients than controls (IFN gamma: PBC 822.7 (1100) pg/ml, controls 2929 (3402) pg/ml, p < 0.05: IL10: PBC 11.1 (15.6) pg/ml, controls 34.7 (63.4) pg/ml, p < 0.05).

Conclusions: In PBC unimpaired T cell proliferation is seen with reduced secretion of both Th-1 (interferon gamma) and Th-2 type (IL10) cytokines. These findings may result from differential subset responses and may help explain the defects of functional immunity seen in PBC.

Citing Articles

Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?.

Smyk D, Rigopoulou E, Zen Y, Abeles R, Billinis C, Pares A World J Gastroenterol. 2012; 18(35):4855-65.

PMID: 23002357 PMC: 3447267. DOI: 10.3748/wjg.v18.i35.4855.

T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC).

Palmer J, Diamond A, Yeaman S, Bassendine M, Jones D Clin Exp Immunol. 1999; 116(1):133-9.

PMID: 10209517 PMC: 1905223. DOI: 10.1046/j.1365-2249.1999.00803.x.

References

Sherlock S, Fox R, James D, Scheuer P, Sharma O . Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet. 1969; 1(7602):959-62. DOI: 10.1016/s0140-6736(69)91860-1. View

Van de Water J, Ansari A, Prindiville T, Coppel R, Ricalton N, Kotzin B . Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med. 1995; 181(2):723-33. PMC: 2191887. DOI: 10.1084/jem.181.2.723. View

Ma Y, Daniel T . Immunochemical analysis of tuberculin purified protein derivative with special reference to United States-Japan antigen 7. J Infect Dis. 1983; 148(3):500-9. DOI: 10.1093/infdis/148.3.500. View

James S, Hoofnagle J, Strober W, Jones E . NIH conference: Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med. 1983; 99(4):500-12. DOI: 10.7326/0003-4819-99-4-500. View

Saxena S, Nouri-Aria K, Anderson M, Eddleston A, Williams R . Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon. Clin Exp Immunol. 1986; 63(3):541-8. PMC: 1577566. View

Kakumu S, Yoshioka K, Tsutsumi Y, Wakita T, Arao M . Production of tumor necrosis factor, interleukin 1, and interferon-gamma by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Clin Immunol Immunopathol. 1990; 56(1):54-65. DOI: 10.1016/0090-1229(90)90169-q. View

Heseltine L, Turner I, Fussey S, Kelly P, James O, Yeaman S . Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression. Gastroenterology. 1990; 99(6):1786-92. DOI: 10.1016/0016-5085(90)90488-m. View

Fussey S, Lindsay J, Fuller C, Perham R, Dale S, James O . Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes. Hepatology. 1991; 13(3):467-74. View

Fowell D, McKnight A, Powrie F, Dyke R, Mason D . Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Immunol Rev. 1991; 123:37-64. DOI: 10.1111/j.1600-065x.1991.tb00605.x. View

10.

Miller L, KAPLAN M . Serum interleukin-2 and tumor necrosis factor-alpha in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4. Am J Gastroenterol. 1992; 87(4):465-70. View

11.

Broome U, Eriksson L, Sundin U, Sundqvist K . Decreased in vitro production of tumor necrosis factor in primary biliary cirrhosis patients. Scand J Gastroenterol. 1992; 27(2):124-8. DOI: 10.3109/00365529209165431. View

12.

Spengler U, Moller A, Jung M, Messer G, Zachoval R, Hoffmann R . T lymphocytes from patients with primary biliary cirrhosis produce reduced amounts of lymphotoxin, tumor necrosis factor and interferon-gamma upon mitogen stimulation. J Hepatol. 1992; 15(1-2):129-35. DOI: 10.1016/0168-8278(92)90024-j. View

13.

Menendez J, Giron J, Manzano L, Garrido A, Abreu L, Albillos A . Deficient interleukin-2 responsiveness of T lymphocytes from patients with primary biliary cirrhosis. Hepatology. 1992; 16(4):931-6. DOI: 10.1002/hep.1840160413. View

14.

Cohen I . The cognitive paradigm and the immunological homunculus. Immunol Today. 1992; 13(12):490-4. DOI: 10.1016/0167-5699(92)90024-2. View

15.

Del Prete G, De Carli M, Almerigogna F, Giudizi M, Biagiotti R, Romagnani S . Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol. 1993; 150(2):353-60. View

16.

Muller C, Knoflach P, Zielinski C . Reduced production of immunoreactive interleukin-1 by peripheral blood monocytes of patients with acute and chronic viral hepatitis. Dig Dis Sci. 1993; 38(3):477-81. DOI: 10.1007/BF01316502. View

17.

Shigeto E, Tasaka H . [Tuberculin sensitivity to purified protein derivatives (PPD) from M. intracellulare (PPD-B), M. kansasii (PPD-Y), M. fortuitum (PPD-Y) and M. tuberculosis (PPDs) among healthy volunteers]. Kekkaku. 1993; 68(4):283-91. View

18.

Orme I, Andersen P, Boom W . T cell response to Mycobacterium tuberculosis. J Infect Dis. 1993; 167(6):1481-97. DOI: 10.1093/infdis/167.6.1481. View

19.

Leon M, Spickett G, Jones D, Bassendine M . CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clin Exp Immunol. 1995; 99(2):233-9. PMC: 1534308. DOI: 10.1111/j.1365-2249.1995.tb05538.x. View

20.

ODonohue J, McFarlane B, Bomford A, Yates M, Williams R . Antibodies to atypical mycobacteria in primary biliary cirrhosis. J Hepatol. 1994; 21(5):887-9. DOI: 10.1016/s0168-8278(94)80255-6. View